Skip to main content
. 2022 Jul 4;20:98. doi: 10.1186/s12958-022-00961-y

Table 1.

Basic patient characteristics and results of hormonal testing in women with FHA and healthy control women

FHA (n = 64) Controls (n = 32) p
Underweight < 18.5 kg/m2 a,b 12 (18.8%) - -
weight loss > 10kga,b 16 (25.0%) - -
Eating disordera,b 19 (29.7%) - -
High level of exercisea,b 26 (40.6%) - -
History of emotionally stressful eventsa,b 15 (23.4%) - -
Age (years)c 26 (21;29) 26 (23;28) 0.551
BMI (kg/m2)c 20.0 (18.6;22.4) 21.5 (19.6;23.6) 0.064
TSH (IU/mL)c 1.67 (1.15;2.16) 1.41 (1.05;1.93) 0.186
FSH (mIU/mL)c 4.5 (3.2;6.2) 5.6 (4.4;6.7) 0.026
LH (mIU/mL)c 2.6 (1.3;5.3) 4.7 (3.6;6.7)  < 0.001
Prolactin (ng/mL)c 8.3 (6.6;12.5) 12.2 (9.4;14.0) 0.003
Oestradiol (pg/mL)c 24 (14;37) 59 (47;68)  < 0.001
Testosterone (pg/mL)c 0.22 (0.13;0.30) 0.24 (0.17;0.31) 0.479
Androstenedione (ng/mL)c 1.45 (0.98;2.37) 1.58 (1.19;2.04) 0.825
DHEAS (µg/mL)c 2.16 (1.53;3.06) 2.16 (1.80;2.74) 0.963
SHBG (nmol/L)c 73.2 (55.1;104.0) 81.2 (61.1;104.5) 0.397
AMH (ng/mL)c 2.57 (1.57;6.18) 3.08 (2.24;4.07) 0.960

Variables are expressed as anumbers (frequencies) or.cmedian (IQR)

Multiple nominations are possible for bFHA causes